Stockreport

PEPFAR and The Global Fund Make Additional Investment in Gilead’s Lenacapavir for HIV Prevention to Further Expand Access

Gilead Sciences, Inc.  (GILD) 
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
PDF – Additional Commitment will Expand Access to Lenacapavir to Reach Another Million People Over the Next 3 Years – FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Science [Read more]